Fujin

Propulsé - Medical Device | Été 2023

About the company

Fujin presents a solution for non-invasive, early and accessible diagnostic of types of cancer related to the respiratory and digestive systems. It is based on
the collection, storage and transportation of exhalation samples, so that they are analyzed in a gold standard equipment, allowing not only diagnostics but also prediction through a risk score determined by AI., Fujin presents a solution for non-invasive, early and accessible diagnostic of types of cancer related to the respiratory and digestive systems. It is based on the collection, storage and transportation of exhalation samples, so that they are analyzed in a gold standard equipment, allowing not only diagnostics but also prediction through a risk score determined by AI.

The founders

Gustavo Chelles
CEO
Miriam Romy Hayashi
CEO

Jumine

Hiver 2023